Advertisement
Surgery
Subscribe to Surgery
View Sample

FREE Email Newsletter

Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices

December 16, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

HAYWARD, Calif., Dec. 16, 2010 /- Solta Medical, Inc. (Nasdaq: SLTM ), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has shipped its one millionth tip for the revolutionary Thermage and Fraxel...

Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 14, 2010  /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Video, High-Tech and Integrated OT Equipment 2011...

Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 14, 2010 /- A new study in the journal Cancer shows that staging prostate cancer that has not metastasized beyond the prostate gland does predict the outcome, prognosis or risk of cancer recurrence after a radical prostatectomy. "This study confirms what many prostate...

Advertisement

MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community

December 13, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Dec. 13, 2010 /- MedShape Solutions, Inc., the world's leading developer of innovative orthopedic medical devices from shape memory materials, today announced a strategic investment and development agreement from In-Q-Tel (IQT), the strategic investment firm that identifies...

Ascension Orthopedics Implants PyroTITANâ„¢ in France

December 13, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 13, 2010 /- Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Implant in France. The PyroTITAN was implanted in a 68-year-old patient suffering from painful...

Injecting New Bone

December 12, 2010 7:34 pm | by Massachusetts Institute of Technology | News | Comments

An artificial bone-like material could speed up recovery from injury.

Phase III Efficacy Data on Bevacizumab Plus Chemotherapy in Early Breast Cancer to be Presented

December 10, 2010 12:34 pm | by AACR | News | Comments

SAN ANTONIO - Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

Circulating Tumor Cells Predicted Recurrence, Death in Patients with Early-stage Breast Cancer

December 10, 2010 9:32 am | by AACR | News | Comments

SAN ANTONIO - The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled patient's risk of cancer relapse and death, and five or more CTCs increased recurrence by 400 percent and death by 300 percent, according to Phase III...

Advertisement

Combination Therapy Reduced HER2-positive Breast Cancers

December 10, 2010 4:35 am | by AACR | News | Comments

SAN ANTONIO - A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held...

Pertuzumab and Trastuzumab Combination Improved Efficacy for Women With HER2-positive Breast Cancer

December 10, 2010 4:34 am | by AACR | News | Comments

SAN ANTONIO - The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer, according to Phase II study results of the NeoSphere neoadjuvant trial.

Phase III Study Compared Neoadjuvant Therapy with Lapatinib or Trastuzumab for Early Breast Cancer

December 10, 2010 4:34 am | by AACR | News | Comments

SAN ANTONIO - Researchers presented Phase III efficacy data from the GeparQuinto study, a head-to-head comparison of neoadjuvant lapatinib and trastuzumab in combination with chemotherapy for patients with early breast cancer, at the 33rd Annual CTRC-AACR San Antonio Breast Cancer...

Covidien Receives FDA 510(k) Clearance for the iDrive(TM) Powered Stapling System

December 9, 2010 4:35 pm | by Covidien | News | Comments

Company's first powered stapling system provides precision, control, access and visibility during open surgical procedures NORTH HAVEN, Conn., Dec 02, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in surgical...

VirtuoSaph® Plus Endoscopic Vessel Harvesting System from Terumo Continues the Advancement of the Minimally Invasive Technique for Coronary and Peripheral Artery Bypass Graft...

December 9, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Dec. 9, 2010 /- Terumo Cardiovascular Systems has announced the introduction of the VirtuoSaph® Plus Endoscopic Vessel Harvesting System following clearance by the U.S. Food and Drug Administration (FDA). (Logo: http://photos.prnewswire.com/prnh/20041217/DEF008LOGO)...

Advertisement

Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer

December 9, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Dec. 9, 2010 /- Osseon Therapeutics, Inc. today named Mr. Gary Coughlen, CPA as the company's Chief Financial Officer, effective immediately. Mr. Coughlen was most recently the Chief Financial Officer of PolyRemedy, Inc., a private-equity medical device company focused...

KLS Martin's SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

TORONTO, Dec. 6, 2010 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, US craniomaxillofacial plate and screw market growth will be driven by uptake of new resorbable polymers and novel implantation techniques. KLS Martin's...

Clinical trials at The Christie: Fact sheet

December 2, 2010 3:34 am | by RealWire | News | Comments

Clinical trial treatments aim to discover if a drug is safe, has side effects, and works better than established treatments. They offer important opportunities for patients to access the most innovative treatments for cancer, giving them the best possible chance of survival or extended...

Reportlinker Adds Global Uro-Gynecological Surgical Devices Industry

November 17, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Nov. 17, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Uro-Gynecological Surgical Devices Industry http://www.reportlinker.com/p092549/Global-Uro-Gynecological-Surgical-Devices-Industry.html This report analyzes the...

Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients

November 17, 2010 2:35 am | by Bio-Medicine.Org | News | Comments

EAST NORRITON, Pa., Nov. 16, 2010 /- Tengion, Inc. (Nasdaq: TNGN ), a leader in regenerative medicine, announced today that the scheduled one-month, post-operative clinical assessment of the first implanted bladder cancer patient in its ongoing clinical trial has been completed as...

Largest Acellular Dermal Allografts for Abdominal Wall Repair Now Available From MTF

November 16, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

EDISON, N.J., Nov. 16, 2010 /- The largest natural allograft available on the market today for hernia and abdominal wall repair has been announced by The Musculoskeletal Transplant Foundation (MTF), the nation's leading provider of allograft tissue. MTF has started distributing 20 cm x 25...

iFuse Implant System™ Receives CE Mark

November 15, 2010 11:40 pm | by Bio-Medicine.Org | News | Comments

SAN JOSE, Calif., Nov. 15, 2010 /- SI-BONE, Inc. (San Jose, California), a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to treat the sacroiliac (SI) joint announced today that it has received a CE mark for its iFuse Implant System™....

Pathfinder Initiates Minimally Invasive Surgical Navigation Study

November 15, 2010 11:40 pm | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Nov. 15, 2010 /- Pathfinder Therapeutics, Inc. has initiated a clinical study to assess the value of Explorer™, its image-guided surgical platform, in minimally invasive liver resections and ablations.  Clinical sites participating in the study include:...

New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group

November 15, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

TORONTO, Nov. 15, 2010 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest peripheral vascular research data for multiple geographies, including the US, Canada, Europe, Asia Pacific, and Latin America. MRG's...

Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel

November 15, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Nov. 15, 2010 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has announced its attendance and exhibition at the 20th Congress of the European Association for...

Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results

November 15, 2010 2:37 am | by Bio-Medicine.Org | News | Comments

BELGRADE, Mont., Nov. 15, 2010 /- Bacterin International Holdings, Inc. ("Bacterin" or the "Company") (OTC Bulletin Board: BIHI ), a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today reported financial results for its third quarter...

Misonix Announces New Distribution Agreement for South Africa

November 12, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Nov. 12, 2010 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Applied Bio Surgical...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading